The PITSLRE protein kinases, hereafter referred to as CDK11 because of their association with the cyclin L regulatory partner, belong to large molecular weight protein complexes that contain RNA polymerase II. These CDK11 p110 complexes have been reported to influence transcription as well as interact with the general pre-mRNA-splicing factor RNPS1. Some of these complexes may also play a role in pre-mRNA splicing. Using a two-hybrid interactive screen, the splicing protein 9G8 was identified as an in vivo partner for CDK11 p110 . The identification of several splicing-related factors as CDK11 p110 interactors along with the close relationship between transcription and splicing indicated that CDK11 p110 might influence splicing activity directly. Immunodepletion of CDK11 p110 from splicing extracts greatly reduced the appearance of spliced products using an in vitro assay system. Moreover, the re-addition of these CDK11 p110 immune complexes to the CDK11 p110 -immunodepleted splicing reactions completely restored splicing activity. Similarly, the addition of purified CDK11 p110 amino-terminal domain protein was sufficient to inhibit the splicing reaction. Finally, 9G8 is a phosphoprotein in vivo and is a substrate for CDK11 p110 phosphorylation in vitro. These data are among the first demonstrations showing that a CDK activity is functionally coupled to the regulation of pre-mRNA-splicing events and further support the hypothesis that CDK11 p110 is in a signaling pathway that may help to coordinate transcription and RNA-processing events.The regulation of transcription and RNA-processing events is complex and, in fact, may be coordinated through the action of several protein kinases that belong to the larger cell division control family (i.e. CDKs) 1 (1-7). These CDKs are not only regulated during the cell cycle, they are undoubtedly part of a much larger signal transduction pathway that is modulated by numerous extracellular and intracellular signals (8). A model is emerging in which the phosphorylation status of the RNA polymerase II (RNAP II) carboxyl-terminal domain (CTD) determines which specific transcription, RNA processing, and polyadenylation factors are recruited to the CTD (5, 7-9). The CTD is heavily phosphorylated in vivo, and a number of protein kinases, particularly CDKs, have been identified that modify this domain in vitro. CDK7, CDK8, and CDK9 are all known CTD protein kinases that regulate different aspects of transcription (10 -13). Sequential phosphorylation of specific amino acid residues within the CTD appears to be regulated by this group of CDKs. These phosphorylation events have been linked to the changes in the composition of RNAP II complexes that are associated with transcription from pre-initiation through termination. However, a functional relationship between a specific CDK and the regulation of pre-mRNA-splicing events has only been inferred (14,15).Based upon the findings reported in this study as well as others (14, 15) demonstrating that the PITSLRE p110 protein kinases associ...